Skip to main content
Terug
ASTH logo

Astrana Health, Inc.

Datakwaliteit: 100%
ASTH
NASDAQ Healthcare Medical - Care Facilities
€ 23,81
▼ € 0,42 (-1,73%)
Marktkapitalisatie: 1,19B
Dagbereik
€ 23,77 € 25,41
52-Weeksbereik
€ 18,08 € 34,80
Volume
420.837
50D / 200D Gem.
€ 23,32 / € 25,81
Vorige Slotkoers
€ 24,23

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E 53,1 0,4
P/B 1,5 2,9
ROE % 3,0 3,8
Net Margin % 0,7 3,9
Rev Growth 5Y % 42,4 10,0
D/E 1,4 0,2

Koersdoel Analisten

Hold
€ 32,75 +37.5%
Low: € 26,00 High: € 40,00
Forward K/W
19,3
Forward WPA
€ 1,24
WPA Groei (sch.)
+0,0%
Omzet Sch.
4 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 3,40
€ 3,24 – € 3,58
 5,4 B 1
FY2029 € 2,81
€ 2,68 – € 2,96
 5 B 1
FY2028 € 2,21
€ 2,11 – € 2,33
 4,6 B 1

Belangrijkste Punten

Revenue grew 42,39% annually over 5 years — strong growth
Earnings declined -47,89% over the past year
ROE of 3,01% is below average
Generating 104,49M in free cash flow
P/E of 53,11 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 14,00%

Groei

Revenue Growth (5Y)
42,39%
Revenue (1Y)56,39%
Earnings (1Y)-47,89%
FCF Growth (3Y)62,24%

Kwaliteit

Return on Equity
3,01%
ROIC3,17%
Net Margin0,71%
Op. Margin2,47%

Veiligheid

Debt / Equity
1,38
Current Ratio1,40
Interest Coverage1,57

Waardering

P/E Ratio
53,11
P/B Ratio1,53
EV/EBITDA23,47
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 56,39% Revenue Growth (3Y) 51,48%
Earnings Growth (1Y) -47,89% Earnings Growth (3Y) -39,14%
Revenue Growth (5Y) 42,39% Earnings Growth (5Y) -24,42%
Profitability
Revenue (TTM) 3,18B Net Income (TTM) 22,49M
ROE 3,01% ROA 1,01%
Gross Margin 9,30% Operating Margin 2,47%
Net Margin 0,71% Free Cash Flow (TTM) 104,49M
ROIC 3,17% FCF Growth (3Y) 62,24%
Safety
Debt / Equity 1,38 Current Ratio 1,40
Interest Coverage 1,57 Dividend Yield 0,01%
Valuation
P/E Ratio 53,11 P/B Ratio 1,53
P/S Ratio 0,38 PEG Ratio -1,09
EV/EBITDA 23,47 Dividend Yield 0,01%
Market Cap 1,19B Enterprise Value 1,84B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3,18B 2,03B 1,39B 1,14B 773,92M
Net Income 22,49M 43,15M 60,72M 45,17M 68,92M
EPS (Diluted) 0,46 0,90 1,29 0,99 1,52
Gross Profit 295,78M 271,39M 214,96M 199,48M 177,77M
Operating Income 78,53M 89,35M 84,61M 104,27M 98,18M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,22B 1,35B 933,36M 966,21M 867,36M
Total Liabilities 1,66B 840,73M 522,59M 407,67M 356,72M
Shareholders' Equity 779,29M 712,72M 614,22M 542,56M 448,17M
Total Debt 1,08B 471,84M 321,01M 229,36M 200,98M
Cash & Equivalents 429,47M 288,46M 293,81M 288,03M 233,10M
Current Assets 863,31M 638,50M 461,51M 428,13M 404,46M
Current Liabilities 615,27M 365,61M 218,67M 148,61M 114,72M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#294 of 1024
55
Growth Price/Sales Ratio Focus (Ken Fisher)
#12 of 616
92

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026
Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026